AstraZeneca (AZN.L) is working as fast as possible to compile data on its COVID-19 vaccine to apply for U.S. approval but the dataset is very big, executives said on Friday as the drugmaker faces delays to its submission. “There’s a lot more data…
AstraZeneca says U.S. data load for U.S. COVID-19 vaccine approval very big
